New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford scientists reporting improvement in neuron communication in mice.

By Carole Tanzer Miller HealthDay ReporterSATURDAY, August 2, 2025 (HealthDay News) — To fend off predators, millipedes release defensive compounds that could one day play a part in treating pain and ...

Parkinson's is a progressive neurodegenerative disease that is currently incurable. It is typically only diagnosed once ...

Insightec, the Miami-based innovator in focused ultrasound to transform patient care, announced July 8 the U.S. Food and Drug ...

Ozzy Osbourne, Black Sabbath frontman, has died at the age of 76. He had suffered from numerous health problems and was ...

About 90,000 people are diagnosed with Parkinson's disease (PD) each year—one person every six minutes. While most people ...

The Phase I trial of ENERGI-F705PD tablet was a randomized, double-blind, placebo-controlled study designed to evaluate the ...

Gene Mack, CEO, GAIN Therapeutics, shares how growing clinician confidence and strong early experiences helped accelerate ...

Scientists find volatile compounds in ear wax may help detect Parkinson's disease earlier than traditional methods, offering a potential inexpensive screening tool.

A recent study linking human pegivirus to Parkinson’s is leading scientists to examine the connection between other viral ...

A progressive neurological disorder affecting 10 million people globally, Parkinson’s can cause disruptive symptoms such as tremors, immobility and loss of balance. Now, scientists at Northwestern ...

UW-Eau Claire students are developing gloves that could help reduce symptoms of Parkinson's disease, and now they have ...